Ozempic vs Mounjaro

A comprehensive comparison of two leading GLP-1 and GIP receptor agonist medications for weight loss and diabetes management.

Written by GLP1Authority Editorial Team · Medically fact-checked
Last updated March 2026 · Read our methodology
Quick answer: Ozempic (semaglutide) is a proven GLP-1 receptor agonist with 15–18% weight loss, strong diabetes control, and better insurance coverage. Mounjaro (tirzepatide) is a newer dual GLP-1/GIP agonist with 20–22% weight loss but higher GI side effects and limited insurance coverage.

Quick Answer

Ozempic (semaglutide) is a GLP-1 receptor agonist approved for type 2 diabetes and weight loss (as Wegovy). It stimulates insulin release, slows gastric emptying, and reduces appetite. Mounjaro (tirzepatide) is a dual GLP-1/GIP receptor agonist offering slightly stronger weight loss effects (~20–22% vs 15–18% for semaglutide). Mounjaro is approved for diabetes and weight loss (as Zepbound).

Choose Ozempic/Wegovy if: You have type 2 diabetes, prefer a proven single-mechanism therapy, or have insurance coverage. Choose Mounjaro/Zepbound if: Maximum weight loss is your goal and you tolerate GI side effects well.

Side-by-Side Comparison Table

Feature Calibrate Ro Body
Starting Price ~$1,649/year (all-inclusive) $99/month (~$1,188/year)
Medications Offered GLP-1s, other medications as needed GLP-1s, add-on compounds available
Coaching Model Dedicated 1:1 health coaching included App-based resources, coaching add-on
Insurance Acceptance High (partnerships with major carriers) Limited (primarily out-of-pocket)
Medical Oversight Board-certified obesity physicians Telehealth providers (variable credentials)
Platform/App Web + mobile app with tracking Mobile-first app with telehealth integration
Cancellation Policy Cancel anytime (notice required) Month-to-month cancellation anytime
Support Hours Coaching calls, office hours, messaging App messaging, in-app support

Who Calibrate Is Best For

Calibrate is the right choice if you prioritize comprehensive medical oversight and prefer working with specialists dedicated to obesity medicine. The program shines for patients with complex health histories, multiple comorbidities, or those who have struggled with previous weight loss attempts and need clinical guidance.

Calibrate's model works well if you:

Medical note: Calibrate's emphasis on board-certified obesity medicine specialists and evidence-based coaching protocols reflects clinical best practices for GLP-1 therapy. This approach aligns with guidelines from the American Academy of Pediatrics and endocrinology societies.

Who Ro Body Is Best For

Ro Body is ideal if you want affordable, accessible GLP-1 therapy with less clinical hand-holding and more autonomy. The program suits patients who are motivated, informed about GLP-1s, and comfortable managing their journey through an app with telehealth support.

Ro Body works best if you:

Important consideration: Ro Body's telehealth providers are not obesity medicine specialists. They manage GLP-1 therapy, but if you have complex metabolic or comorbid conditions, you may benefit more from Calibrate's specialized oversight.

Pricing Breakdown

Calibrate: ~$1,649/year (all-inclusive). If you have insurance, costs can drop significantly. Many major insurance carriers cover Calibrate with proof of clinical obesity (BMI ≥30 or ≥27 with comorbidity).

Ro Body: $99/month (~$1,188/year base). Medications are additional, ranging from $200–$500/month depending on your GLP-1 selection and dosage. Add-on services (coaching, labs) increase costs.

Medications & Supply

Both programs offer access to GLP-1s, but the source differs:

Calibrate: Brand-name GLP-1s (semaglutide for diabetes/weight loss, tirzepatide). Pharmacy-filled via major networks.

Ro Body: GLP-1s from Ro Pharmacy. Mix of brand and compounded options, with direct shipping to your door.

Overall Winner

Calibrate wins for: Medical oversight, insurance integration, dedicated coaching, complex cases.

Ro Body wins for: Affordability, accessibility, speed of enrollment, autonomy.

Choose Calibrate if you want a comprehensive, medically rigorous program with expert oversight and coaching. Choose Ro Body if cost, speed, and simplicity matter most.

References

  1. NEJM — STEP-1 Trial: Semaglutide (Wegovy) Efficacy and Safety
  2. NEJM — SURMOUNT-1 Trial: Tirzepatide (Zepbound) Efficacy and Safety
  3. Mayo Clinic — Semaglutide (Ozempic/Wegovy)
  4. Mayo Clinic — Tirzepatide (Mounjaro/Zepbound)

Get the GLP-1 Insider Brief

Exclusive provider discounts, healthy living guides for your GLP-1 journey, and the latest breakthroughs in peptide science — delivered free.

No spam ever. Unsubscribe anytime.

GLP1Authority.com is an independent review site. We may receive compensation when you click certain links. This does not influence our reviews or rankings. Always consult a healthcare provider before starting any medication. See our affiliate disclosure for details.

Not sure which GLP-1 program is right for you?

2 minutes. No email required.